Arcellx (ACLX) Interest Coverage Ratio (2022 - 2025)

Arcellx's quarterly Interest Coverage Ratio came in at 19787.75 in Q4 2025, down 160.6% year-on-year from 32652.91 in Q4 2024, and down 244.64% quarter-over-quarter from 5741.5 in Q1 2025.

Arcellx has reported Interest Coverage Ratio for 4 years, with the latest figure at 19787.75 in Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio fell 160.6% year-over-year to 19787.75; the trailing twelve-month figure through Sep 2025 stood at 12765.89 (down 36678.72% YoY), and the FY2024 full-year result was 133.56, down 470.93% from the prior year.
  • Interest Coverage Ratio for Q4 2025 stood at 19787.75, down from 5741.5 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 15.35 in Q4 2023, with the low at 19787.75 in Q4 2025.
  • Average Interest Coverage Ratio over 4 years is 3628.14, with a median of 133.26 recorded in 2024.
  • Year-over-year, Interest Coverage Ratio surged 142.83% in 2023 and plunged 49559.97% in 2024.
  • Tracing ACLX's Interest Coverage Ratio over 4 years: stood at 35.85 in 2022, then surged by 142.83% to 15.35 in 2023, then sank by 49559.97% to 7593.14 in 2024, then slumped by 160.6% to 19787.75 in 2025.
  • The last three Interest Coverage Ratio figures came in at 19787.75 (Q4 2025), 5741.5 (Q1 2025), and 7593.14 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 Arcellx 6.48 Bn 6.48 Bn - -19,787.75

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -19,787.75
Mar 31, 2025 -5,741.50
Dec 31, 2024 -7,593.14
Sep 30, 2024 -294.88
Jun 30, 2024 -109.01
Mar 31, 2024 -26.89
Dec 31, 2023 15.35
Sep 30, 2023 -46.78
Jun 30, 2023 -33.59
Mar 31, 2023 -29.69
Dec 31, 2022 -35.85
Sep 30, 2022 -157.51
Jun 30, 2022 -10,430.00
Mar 31, 2022 -6,522.75